Dan Rizzuto
Founder and Chief Executive Officer
Nia Therapeutics
Dr. Dan Rizzuto is the founder and Chief Executive Officer at Nia Therapeutics, where he is developing implantable brain stimulation devices to treat memory disorders due to traumatic brain injury and neurodegenerative diseases such as Alzheimer’s. Dan developed Nia’s core technology at the University of Pennsylvania with funding from DARPA as part of the Restoring Active Memory project, and his team has demonstrated across multiple clinical studies how personalized neurostimulation therapies can be used to improve human memory.
Dan completed his doctoral training at Brandeis University in the neuroscience of human memory, his postdoctoral training at Caltech in brain-machine interfaces, and he previously developed neurostimulation therapies for major depression at Northstar Neuroscience. Dan received the 2015 Researcher of the Year and 2019 Most Promising Startup awards from Neurotech Reports.
Recent Events and Presentations
How Using March-in Rights Would Threaten America’s Research Universities
ITIF hosted a panel discussion with leading experts on innovation policy, technology transfer, and business, who spoke to the practical implications of exercising federal “march-in” rights and why it would be a grave and ill-timed mistake for the U.S. health, competitiveness, and research landscape.
